MedTrace Logo

Different Approaches for the Management of Post-dural Puncture Headache

NCT05253014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-02-23

No results posted yet for this study

Summary

Detecting the efficacy and safety of trans-nasal sphenopalatine ganglion block using either lidocaine 2% or bupivacaine 0.5 % as a treatment line for post-dural puncture headache

Conditions

  • Post-Dural Puncture Headache

Interventions

PROCEDURE

sphenopalatine ganglion block

block of the sphenopalatine ganglion using either lidocaine or bupivacaine to relief postdural puncture headache

DRUG

paracetamol

intravenous paracetamol every 8 hours

Sponsors & Collaborators

  • Bahaa Mohammed Refaie

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-10-30
Completion
2020-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05253014 on ClinicalTrials.gov